Results 291 to 300 of about 462,118 (388)

Two‐year outcomes of a cardiac microcurrent device in chronic heart failure: A first‐in‐human pilot study

ESC Heart Failure, EarlyView.
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Dragana B. Kosevic, Una Radak, Petar Vukovic, Jan D. Schmitto, Kersten Brandes, Peter Goettel, Hans‐Dirk Duengen, Elvis Tahirovic, Marija Zdravkovic, Johannes Mueller, Faouzi Kallel, Marat Fudim, Stefan D. Anker, Jesus Eduardo Rame, Miodrag Peric   +14 more
wiley   +1 more source

Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors. [PDF]

J Med Chem
Cozier GE, Coulson LB, Eyermann CJ, Basarab GS, Schwager SL, Chibale K, Sturrock ED, Acharya KR.   +7 more
europepmc   +1 more source

Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.

, 1985
Herbert G. Bull, Nancy A. Thornberry, Meike Cordes, Arthur A. Patchett, Eugene H. Cordes   +4 more
openalex   +1 more source

Diagnostic value of computed tomography‐based muscle quality and metabolic signatures in heart failure with sarcopenia

ESC Heart Failure, EarlyView.
Abstract Aims Sarcopenia is a major comorbidity in heart failure (HF) patients, but its comprehensive evaluation remains challenging due to resource limitations. Computed tomography (CT) imaging allows opportunistic assessment of both muscle quantity and quality; however, its diagnostic utility and relationships with physical performance and underlying
Wataru Kawaharata, Hidemichi Kouzu, Keishi Ogura, Toshiyuki Yano, Satoshi Katano, Ryo Numazawa, Ryohei Nagaoka, Hiroki Aida, Katsuhiko Ohori, Ryo Nishikawa, Takefumi Fujito, Nobutaka Nagano, Marenao Tanaka, Masato Furuhashi   +13 more
wiley   +1 more source

Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2. [PDF]

Int J Mol Sci
Xu W, Langhans SA, Johnson DK, Stauff E, Kandula VVR, Kecskemethy HH, Averill LW, Yue X.   +7 more
europepmc   +1 more source

Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction

ESC Heart Failure, EarlyView.
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino, Chiharu Nishino, Michikazu Nakai, Kensaku Nishihira, Nehiro Kuriyama, Yoshisato Shibata   +5 more
wiley   +1 more source

Viral Mimetic Bacterial Outer Membrane Vesicles for Targeting Angiotensin-Converting Enzyme 2. [PDF]

Int J Nanomedicine
Ahn G, Yoon HW, Jeong JH, Kim YH, Shin WR, Song MS, Ahn JY.   +6 more
europepmc   +1 more source

The pulmonary artery pulsatility index in patients with severe aortic stenosis undergoing valve replacement

ESC Heart Failure, EarlyView.
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner, Lukas Weber, Philipp K. Haager, Johannes Rigger, Joannis Chronis, Peter Ammann, Roman Brenner, Martin O. Schmiady, Hans Rickli, Micha T. Maeder   +9 more
wiley   +1 more source

Angiotensin-Converting Enzyme Inhibition as a Potential Risk Factor for Periprosthetic Joint Infection Following Total Knee Arthroplasty. [PDF]

Arthroplast Today
Trikha R, Cevallos N, Zhang AL, Narayan SM, Photopoulos C, Stavrakis A, Bernthal NM.   +6 more
europepmc   +1 more source